etiron has been researched along with Myocardial Ischemia in 1 studies
etiron: a nitric oxide synthase inhibitor; RN given refers to parent cpd; structure
Myocardial Ischemia: A disorder of cardiac function caused by insufficient blood flow to the muscle tissue of the heart. The decreased blood flow may be due to narrowing of the coronary arteries (CORONARY ARTERY DISEASE), to obstruction by a thrombus (CORONARY THROMBOSIS), or less commonly, to diffuse narrowing of arterioles and other small vessels within the heart. Severe interruption of the blood supply to the myocardial tissue may result in necrosis of cardiac muscle (MYOCARDIAL INFARCTION).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Martin, C | 1 |
| Schulz, R | 1 |
| Post, H | 1 |
| Boengler, K | 1 |
| Kelm, M | 1 |
| Kleinbongard, P | 1 |
| Gres, P | 1 |
| Skyschally, A | 1 |
| Konietzka, I | 1 |
| Heusch, G | 1 |
1 other study available for etiron and Myocardial Ischemia
| Article | Year |
|---|---|
Microdialysis-based analysis of interstitial NO in situ: NO synthase-independent NO formation during myocardial ischemia.
Topics: Animals; Biomarkers; Extracellular Fluid; Isothiuronium; Microdialysis; Microscopy, Confocal; Mitoch | 2007 |